RLMD Relmada Therapeutics, Inc.

NASDAQ
$3.83

Relmada Therapeutics, Inc. (RLMD) Earnings News

Earnings press releases, previews and reviews for Relmada Therapeutics, Inc. (RLMD), newest first.